Intermittent fasting and performance: The iFast clinical trial protocol

dc.contributor.authorEl-Outa, Abbass Z.R.
dc.contributor.authorGhandour, Lara
dc.contributor.authorHamade, Hani N.
dc.contributor.authorBorgi, Cécile
dc.contributor.authorFares, Elie Jacques
dc.contributor.authorGherbal, Tarek
dc.contributor.authorMufarrij, Afif Jean
dc.contributor.departmentEmergency Medicine
dc.contributor.departmentDepartment of Nutrition and Food Sciences
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.facultyFaculty of Agricultural and Food Sciences (FAFS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:41:56Z
dc.date.available2025-01-24T11:41:56Z
dc.date.issued2022
dc.description.abstractThere is increasing evidence from animal and human studies suggesting that fasting can play a role in disease prevention, weight control and longevity. However, few studies have compared exercise performances in individuals adhering to an intermittent fasting (IF) in comparison to individuals who are not. Given the rising popularity of IF we aim to investigate whether this type eating pattern will improve cardiovascular performance over a period of 12 weeks through VO2 max measurements in participants from a Lebanese community. Additionally, we will study the variation of different health parameters, physical performance and biomarkers potentially affected by IF. Participants will be recruited from a large university community and randomized into 4 arms. Baseline information will be collected from all participants, which includes biological, physical, nutritional, medical and psychological data. Two arms will follow a time-restricted fasting diet with and without physical exercise, one arm will exercise without fasting, and one will act as a control group. Throughout the study, measurements will be repeated, and data analysis will follow to evaluate results. © 2021
dc.identifier.doihttps://doi.org/10.1016/j.conctc.2021.100766
dc.identifier.eid2-s2.0-85121909007
dc.identifier.urihttp://hdl.handle.net/10938/29909
dc.language.isoen
dc.publisherElsevier Inc.
dc.relation.ispartofContemporary Clinical Trials Communications
dc.sourceScopus
dc.subjectAerobic exercise
dc.subjectExercise performance
dc.subjectFatmax
dc.subjectHealth biomarkers
dc.subjectIntermittent fasting
dc.subjectMaximal oxygen consumption
dc.subjectNutrition
dc.subjectSports medicine
dc.subjectVo2max
dc.subjectWeight loss
dc.subjectGlucose
dc.subjectLuteinizing hormone
dc.subjectAdult
dc.subjectAnxiety
dc.subjectAppetite
dc.subjectArticle
dc.subjectBlood glucose monitoring
dc.subjectBody weight
dc.subjectCardiovascular performance
dc.subjectClinical trial protocol
dc.subjectConcentration loss
dc.subjectControlled study
dc.subjectDizziness
dc.subjectExercise
dc.subjectFatigue
dc.subjectFemale
dc.subjectGlucose blood level
dc.subjectGlycemic index
dc.subjectHeadache
dc.subjectHuman
dc.subjectHunger
dc.subjectIrritability
dc.subjectLebanon
dc.subjectMajor clinical study
dc.subjectMale
dc.subjectMaximal oxygen uptake
dc.subjectMenstrual irregularity
dc.subjectMetabolism
dc.subjectMood change
dc.subjectMuscle weakness
dc.subjectMyalgia
dc.subjectNutritional assessment
dc.subjectSleep
dc.titleIntermittent fasting and performance: The iFast clinical trial protocol
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-1952.pdf
Size:
1.67 MB
Format:
Adobe Portable Document Format